Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-012680
Filing Date
2021-03-12
Accepted
2021-03-12 06:44:38
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 acet-s3.htm S-3 850717
2 EX-1.2 acet-ex12_105.htm EX-1.2 304336
3 EX-4.4 acet-ex44_107.htm EX-4.4 526909
4 EX-4.5 acet-ex45_106.htm EX-4.5 534662
5 EX-5.1 acet-ex51_104.htm EX-5.1 25014
6 EX-5.2 acet-ex52_103.htm EX-5.2 13031
7 EX-23.1 acet-ex231_156.htm EX-23.1 3876
8 EX-23.2 acet-ex232_158.htm EX-23.2 2176
9 GRAPHIC ga1elq0dniej000006.jpg GRAPHIC 1927
10 GRAPHIC ga1elq0dniej000004.jpg GRAPHIC 17552
11 GRAPHIC ga1elq0dniej000003.jpg GRAPHIC 3393
12 GRAPHIC ga1elq0dniej000001.jpg GRAPHIC 2267
13 GRAPHIC ga1elq0dniej000005.jpg GRAPHIC 2267
14 GRAPHIC ga1elq0dniej000002.jpg GRAPHIC 3404
  Complete submission text file 0001564590-21-012680.txt   2305161
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254193 | Film No.: 21735368
SIC: 2834 Pharmaceutical Preparations